{ "cik": 1590750, "cik_padded": "0001590750", "entityName": "Viridian Therapeutics, Inc.\\DE", "fiscal_years": [ { "accn": "0001590750-26-000007", "filed": "2026-02-26", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 495000.0, "free_cash_flow": -276886000.0, "net_income": -342601000.0, "operating_cash_flow": -276391000.0, "operating_income": -363395000.0, "revenue": 70849000.0, "stockholders_equity": 722167000.0, "total_assets": 899418000.0, "total_liabilities": 177251000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.24544322850531802, "revenue_growth_yoy": 233.59933774834437, "roa_avg2y": -0.417342694483747, "roa_period_end": -0.38091410223055355, "roe_avg2y": -0.49160500098292015, "roe_period_end": -0.47440688926522534 } }, { "accn": "0001590750-26-000007", "filed": "2026-02-26", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 511000.0, "free_cash_flow": -232830000.0, "net_income": -269949000.0, "operating_cash_flow": -232319000.0, "operating_income": -299035000.0, "revenue": 302000.0, "stockholders_equity": 671639000.0, "total_assets": 742403000.0, "total_liabilities": 70764000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10536017116337795, "revenue_growth_yoy": -0.03821656050955414, "roa_avg2y": -0.4379349251760385, "roa_period_end": -0.36361517935676446, "roe_avg2y": -0.4847956424800725, "roe_period_end": -0.40192573689139555 } }, { "accn": "0001590750-26-000007", "filed": "2026-02-26", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 898000.0, "free_cash_flow": -185068000.0, "net_income": -237734000.0, "operating_cash_flow": -184170000.0, "operating_income": -254450000.0, "revenue": 314000.0, "stockholders_equity": 442022000.0, "total_assets": 490424000.0, "total_liabilities": 48402000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10950133703752302, "revenue_growth_yoy": -0.8227990970654627, "roa_avg2y": -0.513733434898408, "roa_period_end": -0.4847519697241571, "roe_avg2y": -0.568003765443455, "roe_period_end": -0.5378329585405252 } }, { "accn": "0001590750-26-000007", "filed": "2026-02-26", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 797000.0, "free_cash_flow": -94635000.0, "net_income": -129874000.0, "operating_cash_flow": -93838000.0, "operating_income": -134304000.0, "revenue": 1772000.0, "stockholders_equity": 395064000.0, "total_assets": 435091000.0, "total_liabilities": 40027000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10131776117287325, "revenue_growth_yoy": -0.40195747553155586, "roa_avg2y": -0.40661865998747654, "roa_period_end": -0.29849847503166005, "roe_avg2y": -0.44570506880812655, "roe_period_end": -0.32874167223538464 } }, { "accn": "0001590750-25-000004", "filed": "2025-03-03", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 338000.0, "free_cash_flow": -54919000.0, "net_income": -79413000.0, "operating_cash_flow": -54581000.0, "operating_income": -79728000.0, "revenue": 2963000.0, "stockholders_equity": 187716000.0, "total_assets": 203709000.0, "total_liabilities": 15993000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.08519785207441027, "revenue_growth_yoy": 1.821904761904762, "roa_avg2y": -0.474158417023919, "roa_period_end": -0.3898355006406197, "roe_avg2y": -0.516082702686895, "roe_period_end": -0.4230486479575529 } }, { "accn": "0001590750-24-000007", "filed": "2024-02-27", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 42000.0, "free_cash_flow": -29821000.0, "net_income": -110715000.0, "operating_cash_flow": -29779000.0, "operating_income": -110380000.0, "revenue": 1050000.0, "stockholders_equity": 120037000.0, "total_assets": 131255000.0, "total_liabilities": 11218000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.09345451819022468, "revenue_growth_yoy": -0.7646267652992602, "roa_avg2y": -1.3709392819331712, "roa_period_end": -0.8435107234010133, "roe_avg2y": -1.6306677173008521, "roe_period_end": -0.9223406116447428 } }, { "accn": "0001590750-22-000004", "filed": "2022-03-11", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 84000.0, "free_cash_flow": -36140000.0, "net_income": -41873000.0, "operating_cash_flow": -36056000.0, "operating_income": -41979000.0, "revenue": 4461000.0, "stockholders_equity": 15754000.0, "total_assets": 30262000.0, "total_liabilities": 14508000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.9209089754982861, "revenue_growth_yoy": -0.46804197471977105, "roa_avg2y": -0.8686533414930141, "roa_period_end": -1.3836825061132774, "roe_avg2y": -1.2481146979045574, "roe_period_end": -2.657928145232957 } }, { "accn": "0001590750-21-000029", "filed": "2021-03-26", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 445000.0, "free_cash_flow": -27289000.0, "net_income": -32703000.0, "operating_cash_flow": -26844000.0, "operating_income": -33084000.0, "revenue": 8386000.0, "stockholders_equity": 51344000.0, "total_assets": 66147000.0, "total_liabilities": 14803000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2883102212527267, "revenue_growth_yoy": 1.094928803397452, "roa_avg2y": -0.5513538119162423, "roa_period_end": -0.4943988389496122, "roe_avg2y": -0.7279141718788257, "roe_period_end": -0.6369390775942662 } }, { "accn": "0001590750-20-000021", "filed": "2020-03-13", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 246000.0, "free_cash_flow": -28413000.0, "net_income": -26512000.0, "operating_cash_flow": -28167000.0, "operating_income": -26532000.0, "revenue": 4003000.0, "stockholders_equity": 38510000.0, "total_assets": 52481000.0, "total_liabilities": 13971000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3627888860036354, "roa_avg2y": -0.686474799653034, "roa_period_end": -0.5051733008136278, "roe_avg2y": 2.2649182008457562, "roe_period_end": -0.6884445598545832 } }, { "accn": "0001590750-19-000013", "filed": "2019-03-14", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 250000.0, "free_cash_flow": -15005000.0, "net_income": -17274000.0, "operating_cash_flow": -14755000.0, "operating_income": -16987000.0, "stockholders_equity": -61921000.0, "total_assets": 24760000.0, "total_liabilities": 9705000.0 }, "period_end": "2016-12-31", "ratio_units": { "roa_period_end": "ratio" }, "ratios": { "roa_period_end": -0.6976575121163167 } } ], "latest_filing": { "accn": "0001590750-26-000007", "filed": "2026-02-26", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001590750.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001590750.json" }, "ticker": "VRDN" }